David Roberts's most recent trade in Lemaitre Vascular Inc was a trade of 5 Dividend Equivalent Rights done . Disclosure was reported to the exchange on May 29, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 5 | 22 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 4 | 22 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3 | 6 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3 | 32 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3 | 31 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 1 | 24 | - | - | Dividend Equivalent Rights | |
HNI Corp. | David M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 2,666 | 5,772 (0%) | 0% | 0 | Common Stock | |
SPX Technologies Inc | David A. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 892 | 40,593 (0%) | 0% | - | Common Stock | |
HNI Corp. | David M. Roberts | Director | Grant, award, or other acquisition of securities at price $ 48.76 per share. | 13 May 2025 | 215 | 5,987 (0%) | 0% | 48.8 | 10,483 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 4 | 17 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 4 | 18 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 3 | 28 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 3 | 27 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 3 | 3 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2025 | 1 | 22 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.48 per share. | 07 Mar 2025 | 2,818 | 17,976 (0%) | 0% | 35.5 | 99,983 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,818 | 123 | - | - | Stock Option (Right to Buy) | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 685 | 15,356 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.85 per share. | 28 Feb 2025 | 203 | 15,158 (0%) | 0% | 91.9 | 18,646 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5 | 12 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 5 | 15,361 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 741 | 741 | - | - | Stock Option (Right to Buy) | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 129 | 14,671 (0%) | 0% | 0 | Common Stock | |
HNI Corp. | David Roberts M. | Director | Grant, award, or other acquisition of securities at price $ 48.23 per share. | 12 Feb 2025 | 215 | 3,106 (0%) | 0% | 48.2 | 10,369 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.12 per share. | 20 Dec 2024 | 115 | 14,542 (0%) | 0% | 92.1 | 10,594 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 17 | 14,657 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | Roberts B. David | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2024 | 17 | 2 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | Roberts David B. | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.28 per share. | 11 Dec 2024 | 197 | 14,837 (0%) | 0% | 100.3 | 19,755 | Common Stock |
Lemaitre Vascular Inc | B. David Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.28 per share. | 11 Dec 2024 | 197 | 14,640 (0%) | 0% | 100.3 | 19,755 | Common Stock |
Lemaitre Vascular Inc | B. David Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.00 per share. | 11 Dec 2024 | 196 | 15,012 (0%) | 0% | 101 | 19,796 | Common Stock |
Lemaitre Vascular Inc | B. David Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 18 | 15,208 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 18 | 20 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | B. Roberts David | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 11 | 15,034 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | B. David Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 11 | 15,023 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | Roberts B. David | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 11 | 25 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | B. David Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 11 | 24 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.12 per share. | 09 Dec 2024 | 169 | 15,190 (0%) | 0% | 101.1 | 17,089 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 4 | 15,359 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 4 | 13 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 7,662 | 7,662 | - | - | Stock Option (Right to Buy) | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2024 | 1,335 | 15,355 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 3 | 36 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 3 | 17 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 3 | 35 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 2 | 38 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.47 per share. | 02 Dec 2024 | 106 | 14,020 (0%) | 0% | 105.5 | 11,180 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 12 | 14,126 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 12 | 14 | - | - | Dividend Equivalent Rights | |
HNI Corp. | David Roberts | Director | Grant, award, or other acquisition of securities at price $ 54.84 per share. | 08 Nov 2024 | 189 | 2,891 (0%) | 0% | 54.8 | 10,365 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 4 | 14 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 3 | 33 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 3 | 32 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 2 | 36 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 1 | 26 | - | - | Dividend Equivalent Rights | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 77,520 | 38,760 | - | - | Employee Stock Option (Right to Buy) | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 13 Aug 2024 | 77,520 | 673,290 (0%) | 0% | 27 | 2,093,040 | Class A Common Stock |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.69 per share. | 13 Aug 2024 | 77,520 | 750,810 (0%) | 0% | 13.7 | 1,061,249 | Class A Common Stock |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 51,498 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.01 per share. | 13 Aug 2024 | 51,498 | 673,290 (0%) | 0% | 27.0 | 1,390,940 | Class A Common Stock |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.62 per share. | 13 Aug 2024 | 51,498 | 724,788 (0%) | 0% | 12.6 | 649,905 | Class A Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 82.07 per share. | 13 Aug 2024 | 3,063 | 14,114 (0%) | 0% | 82.1 | 251,380 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 2,941 | 2,941 | - | - | Stock Option (Right to Buy) | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.48 per share. | 13 Aug 2024 | 2,941 | 17,177 (0%) | 0% | 35.5 | 104,347 | Common Stock |
HNI Corp. | David Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 2,288 | 2,702 (0%) | 0% | 0 | Common Stock | |
HNI Corp. | David Roberts | Director | Grant, award, or other acquisition of securities at price $ 50.07 per share. | 13 Aug 2024 | 414 | 414 (0%) | 0% | 50.1 | 20,729 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.56 per share. | 13 Aug 2024 | 122 | 14,236 (0%) | 0% | 23.6 | 2,874 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 122 | 0 | - | - | Stock Option (Right to Buy) | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4 | 10 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4 | 28 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 4 | 29 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 2 | 34 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 1 | 24 | - | - | Dividend Equivalent Rights | |
Flowserve Corp. | David E. Roberts | Director | 16 May 2024 | 3,210 | 51,283 | - | - | Phantom Stock | ||
SPX Technologies Inc | David A. Roberts | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 998 | 39,701 (0%) | 0% | - | Common Stock | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Sale of securities on an exchange or to another person at price $ 75.62 per share. | 06 May 2024 | 5,025 | 14,114 (0%) | 0% | 75.6 | 379,991 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 5 | 5 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 4 | 25 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 4 | 24 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 3 | 31 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 1 | 23 | - | - | Dividend Equivalent Rights | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 93,867 | 691,989 (0%) | 0% | 0 | Class A Common Stock | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.16 per share. | 04 Mar 2024 | 25,653 | 666,336 (0%) | 0% | 22.2 | 568,470 | Class A Common Stock |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 9,569 | 0 | - | - | Restricted Stock Units | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 9,569 | 675,905 (0%) | 0% | 0 | Class A Common Stock | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 9,131 | 600,617 (0%) | 0% | 0 | Class A Common Stock | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 9,131 | 9,131 | - | - | Restricted Stock Units | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.60 per share. | 04 Mar 2024 | 2,615 | 673,290 (0%) | 0% | 21.6 | 56,484 | Class A Common Stock |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.16 per share. | 04 Mar 2024 | 2,495 | 598,122 (0%) | 0% | 22.2 | 55,289 | Class A Common Stock |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 52,447 | 52,447 | - | - | Restricted Stock Units | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 16,106 | 32,212 | - | - | Restricted Stock Units | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 16,106 | 595,887 (0%) | 0% | 0 | Class A Common Stock | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 15,845 | 47,535 | - | - | Restricted Stock Units | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 15,845 | 584,215 (0%) | 0% | 0 | Class A Common Stock | |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.88 per share. | 01 Mar 2024 | 4,434 | 579,781 (0%) | 0% | 22.9 | 101,450 | Class A Common Stock |
Verra Mobility Corp - Ordi... | David Roberts | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.88 per share. | 01 Mar 2024 | 4,401 | 591,486 (0%) | 0% | 22.9 | 100,695 | Class A Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 2,649 | 19,329 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.00 per share. | 29 Feb 2024 | 196 | 19,139 (0%) | 0% | 70 | 13,720 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 6 | 20 | - | - | Dividend Equivalent Rights | |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 6 | 19,335 (0%) | 0% | 0 | Common Stock | |
Lemaitre Vascular Inc | Roberts David B. | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.56 per share. | 13 Feb 2024 | 4,244 | 16,682 (0%) | 0% | 23.6 | 99,989 | Common Stock |
Lemaitre Vascular Inc | David B. Roberts | Director, President and Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 4,244 | 122 | - | - | Stock Option (Right to Buy) |